Advances in MS-based Single-cell Proteomics

About this Class

Please register here to attend. Webinar Presenter: Dr Tao Liu, Pacific Northwest National Laboratory Join the Office of Cancer Clinical Proteomics Research (OCCPR) for our 2021 OCCPR webinar series! Hear from our Clinical Proteomic Tumor Analysis Consortium (CPTAC) scientists about their research and current projects. Mass spectrometry (MS)-based proteomics enables the characterization of the human proteome at a genome scale. Recent advances in sample handling platforms and proteomic analysis strategies also allow for analysis of protein expression and phosphorylation in very small populations of cells, even single cells. These advances in single-cell proteomics hold great potential for improved understanding of biological heterogeneity underlying cancer for translational applications. The CPTAC program is run by the OCCPR which aims to improve prevention, early detection, diagnosis, and treatment of cancer by bringing more understanding to the molecular underpinning of cancer through proteo-genome science and technology development and providing community resources (data and reagents). To sign up for CPTAC updates click here. For more information, please contact La’Toya Kelly.